Friday | 5 December, 2008
Australian Biotechnology News

Stories about: SGI

  • +

    Promising faster returns could be dangerous, bio-IT expert warns 13/02/2003 15:43:20

    Drug development companies are dipping into dangerous waters by trying to persuade investors that the industry can achieve the same improvements in product cycle times delivered by other manufacturing industries, warns US-based bio-IT specialist Dan Stevens.
Additional Resources
Newsletter Subscription
Sign up for our Australian Life Scientist newsletters!
 
Sponsored Links